Results 141 to 150 of about 69,722 (292)
"Glycohemoglobin," not "glycated hemoglobin" or "glycosylated hemoglobin"
openaire +2 more sources
Summary Management of type 2 diabetes includes medications that can unintentionally increase obesity and insulin resistance. This unblinded, single‐centre, randomised controlled trial focused on rural Australian adults with type 2 diabetes (aged 18–75 and body mass index [BMI] >30 kg/m2), measuring the effectiveness of a tailored interdisciplinary ...
Giuliana O. Murfet +3 more
wiley +1 more source
Abstract Aims To assess the glycaemic efficacy and safety of CT‐868, a cAMP signal‐biased, dual glucagon‐like peptide‐1/glucose‐dependent insulinotropic polypeptide receptor agonist, in participants with type 2 diabetes (T2D). Materials and Methods This 26‐week (W), phase 2, randomized, double‐blind placebo‐controlled trial enrolled adults with T2D ...
Manu V. Chakravarthy +10 more
wiley +1 more source
Abstract Aims Automated insulin delivery (AID) is part of the standard of care for type 1 diabetes (T1D), but real‐world evidence (RWE) comparing AID systems remains limited. A systematic review and meta‐analysis was conducted for outcomes across commercially available AID systems in real‐world settings.
Johannes Pöhlmann +10 more
wiley +1 more source
Abstract Maternally inherited diabetes and deafness (MIDD) is a mitochondrial disorder usually caused by the variant m.3243A>G in the MT‐TL1 gene. We have proposed that diabetes in MIDD arises from a combination of insulin resistance and impaired β‐cell function that is more likely to occur in the presence of high skeletal muscle heteroplasmy and ...
Ahsen Chaudhry +2 more
wiley +1 more source
The impact of glycated hemoglobin trajectories on hypertension risk: a retrospective cohort study. [PDF]
Sun Y +12 more
europepmc +1 more source

